METHOTREXATE 50 mg/2mL
METHOTREXATE · INJECTION, SOLUTION · Eugia US LLC
No Recall HistoryCurrently in Shortage
Plain English
METHOTREXATE is a injection, solution containing methotrexate at 50 mg/2mL, taken intramuscular. Manufactured by Eugia US LLC.
Key Facts
- Brand Name
- METHOTREXATE
- Generic Name
- METHOTREXATE
- NDC Code (Product)
55150-510- Manufacturer
- Eugia US LLC
- Strength
- 50 mg/2mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- ANDA201529
- Marketing Start
- 09/11/2024
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
drug ineffective92,090 reports
rheumatoid arthritis42,116 reports
arthralgia40,039 reports
off label use39,186 reports
pain38,989 reports
fatigue32,423 reports
nausea28,352 reports
joint swelling24,636 reports
drug intolerance24,176 reports
condition aggravated23,413 reports
Frequently Asked Questions
What is METHOTREXATE used for?
METHOTREXATE contains METHOTREXATE. It is a injection, solution taken intramuscular. Consult your doctor for specific uses.
Is METHOTREXATE a controlled substance?
METHOTREXATE is not classified as a controlled substance by the DEA.
What is the generic name for METHOTREXATE?
The generic name for METHOTREXATE is METHOTREXATE. There are 11 other brand versions of METHOTREXATE.
What is the NDC code for METHOTREXATE 50 mg/2mL?
The NDC (National Drug Code) for METHOTREXATE 50 mg/2mL is 55150-510, listed by Eugia US LLC.